Skip to main content
Clinical Trials/CTRI/2016/05/006925
CTRI/2016/05/006925
Not yet recruiting
未知

Dexmedetomidine versus midazolam for sedation in mechanically ventilated children in pediatric intensive care unit: A randomized double blind controlled trial

Director JIPMER0 sites430 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Children aged â?¤ 12 years admitted in PICU for mechanical ventilation with anticipated to require sedation for more than 24 hours.
Sponsor
Director JIPMER
Enrollment
430
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Director JIPMER

Eligibility Criteria

Inclusion Criteria

  • Children aged \<\= 12 years admitted in PICU for mechanical ventilation with anticipated to require sedation for \>24 hours.

Exclusion Criteria

  • 1\. Children with unstable hemodynamics at the time of enrollment (Mean arterial blood pressure \<\= 5th percentile for age, sex, length/height with \>\=2 vasoactive therapy support and/or requiring on going resuscitation)
  • 2\. Children requiring mechanical ventilation for neuromuscular diseases
  • 3\. Children with severe central nervous system pathology like raised intracranial pressure irrespective of causes, acute cerebrovascular accident, status epilepticus etc.
  • 4\. Children with developmental delay
  • 5\. Children with evidence of myocardial dysfunction (ejection fraction \< 30%) and bradycardia (heart rate \<60/min)
  • 6\. Requiring dialysis irrespective of type at the time of enrollment.
  • 7\. Received general anesthesia 24 hours prior to or planned after the start of study drug infusion.
  • 8\. Children with severe liver pathology like acute liver failure, hepatic encephalopathy, chronic liver diases etc.
  • 9\. Children with trauma and burns as an admitting diagnosis.
  • 10\. Children requiring neuromuscular blockade infusion other than for intubation.

Outcomes

Primary Outcomes

Not specified

Similar Trials